KRAS mutations in non-small-cell lung cancer and colorectal cancer: Implications for EGFR-targeted therapies
Maus, M.K.H, Grimminger, P.P, Mack, P.C, Astrow, S.H, Stephens, C, Zeger, G, Hsiang, J, Brabender, J, Friedrich, M, Alakus, H, Hölscher, A.H, Lara, P, Danenberg, K.D, Lenz, H.J, Gandara, D.R
Published in Lung cancer (Amsterdam, Netherlands) (01.02.2014)
Published in Lung cancer (Amsterdam, Netherlands) (01.02.2014)
Get full text
Journal Article
Clinical efficacy of atezolizumab (Atezo) in PD-L1 subgroups defined by SP142 and 22C3 IHC assays in 2L+ NSCLC: Results from the randomized OAK study
Gadgeel, S., Kowanetz, M., Zou, W., Hirsch, F.R., Kerr, K.M., Gandara, D.R., Barlesi, F., Park, K., McCleland, M., Koeppen, H., Ballinger, M., Sandler, A., Hegde, P.S., Rittmeyer, A.
Published in Annals of oncology (01.09.2017)
Published in Annals of oncology (01.09.2017)
Get full text
Journal Article
P0084 Eribulin in patients with advanced urothelial cancer and previously treated with platinum and anti-microtubule chemotherapy: A phase 2 California Cancer Consortium trial
Quinn, D.I, Twardowski, P.W, Ruel, N, Groshen, S.G, Dorff, T.B, Pal, S.K, Stadler, W.M, Gandara, D.R, Lara Jr, P.N, Newman, E.M
Published in European journal of cancer (1990) (01.07.2015)
Published in European journal of cancer (1990) (01.07.2015)
Get full text
Journal Article
Origin and prognostic value of circulating KRAS mutations in lung cancer patients
Gautschi, O, Huegli, B, Ziegler, A, Gugger, M, Heighway, J, Ratschiller, D, Mack, P.C, Gumerlock, P.H, Kung, H.J, Stahel, R.A, Gandara, D.R, Betticher, D.C
Published in Cancer letters (08.09.2007)
Published in Cancer letters (08.09.2007)
Get full text
Journal Article
Phase II Study of Nivolumab (anti-PD-1, BMS-936558, ONO-4538) in Patients with Advanced, Refractory Squamous Non-Small Cell Lung Cancer
Ramalingam, S.S, Mazières, J, Planchard, D, Stinchcombe, T.E, Dy, G.K, Antonia, S.J, Horn, L, Lena, H, Minenza, E, Mennecier, B, Otterson, G.A, Campos, L.T, Gandara, D.R, Levy, B.P, Nair, S.G, Zalcman, G, Wolf, J, Baudelet, C, Lestini, B.J, Rizvi, N.A
Published in International journal of radiation oncology, biology, physics (01.12.2014)
Published in International journal of radiation oncology, biology, physics (01.12.2014)
Get full text
Journal Article
Initial Cooperative Group Experience of Bevacizumab (Bev) Plus Concomitant Chemoradiation Therapy (CRT) in Patients With Inoperable Locally Advanced Stage III Non-small Cell Lung Cancer (LA-NSCLC): Preliminary Results of S0533
Thomas, C.R, Moon, J, Gaspar, L.E, Raben, D, Fitzgerald, T.J, Wozniak, A.J, Kelly, K, Mack, P.C, Pandya, K.J, Gandara, D.R
Published in International journal of radiation oncology, biology, physics (01.11.2012)
Published in International journal of radiation oncology, biology, physics (01.11.2012)
Get full text
Journal Article
Advanced bronchioloalveolar carcinoma: a phase II trial of paclitaxel by 96-hour infusion (SWOG 9714): a Southwest Oncology Group study
West, H. L., Crowley, J. J., Vance, R. B., Franklin, W. A., Livingston, R. B., Dakhil, S. R., Giguere, J. K., Rivkin, S. E., Kraut, M., Chansky, K., Gandara, D. R.
Published in Annals of oncology (01.07.2005)
Published in Annals of oncology (01.07.2005)
Get full text
Journal Article
Efficacy of chemotherapy and atezolizumab in patients with non-small-cell lung cancer receiving antibiotics and proton pump inhibitors: pooled post hoc analyses of the OAK and POPLAR trials
Chalabi, M., Cardona, A., Nagarkar, D.R., Dhawahir Scala, A., Gandara, D.R., Rittmeyer, A., Albert, M.L., Powles, T., Kok, M., Herrera, F.G.
Published in Annals of oncology (01.04.2020)
Published in Annals of oncology (01.04.2020)
Get full text
Journal Article
1853P Risk model for overall survival (OS) based on composite patient-reported outcomes (PROs) in aNSCLC patients treated with first-line (1L) cemiplimab-based therapy
Gandara, D.R., Gogishvili, M., Sezer, A., Makharadze, T., Gumus, M., Yan, E., Harnett, J., Rietschel, P., Quek, R.
Published in Annals of oncology (01.09.2024)
Published in Annals of oncology (01.09.2024)
Get full text
Journal Article
P2.12-03 External Validation of a Novel CT-Based Prognostic Radiomic Signature in Patients with Metastatic NSCLC in SWOG S0819 Phase III Randomized Trial
Dercle, L., Gomez, D., Zhao, B., Kelly, K., Herbst, R.S., Redman, M.W., Gandara, D.R., Schwartz, L.H.
Published in Journal of thoracic oncology (01.09.2022)
Published in Journal of thoracic oncology (01.09.2022)
Get full text
Journal Article
1359P Lack of Abscopal effect and radiotherapy-induced lymphocyte depletion in advanced non-small cell lung cancer (NSCLC) patients treated with atezolizumab and radiotherapy
Meisel, A., von Moos, R., Haider, A., Holer, L., Hayoz, S., Bengs, S., Treyer, V., Abedian, R., Websky, S., Rothschild, S.I., Hochmair, M.J., Gandara, D.R., Cappuzzo, F., Reck, M., Stenner-Liewen, F., Mark, M.T.
Published in Annals of oncology (01.09.2024)
Published in Annals of oncology (01.09.2024)
Get full text
Journal Article
1309P A genomic scar based signature (HRDsig) and biallelic BRCA alterations identify a homologous recombination deficiency (HRD) phenotype of non-small cell lung cancer (NSCLC) potentially actionable to the PARP inhibitor rucaparib: Post-hoc analysis of lung-MAP substudy S1900A
Riess, J.W., Miao, J., Wheatley-Price, P., Reckamp, K.L., Kozono, D., Redman, M.W., Edelman, M.J., Faller, B., Villaruz, L., Corum, L., Gowda, A., Srkalovic, G., Osarogiagbon, R., Baumgart, M., Gandara, D.R., Sokol, E.S., Borghaei, H., Gray, J.E., Herbst, R.S., Kelly, K.
Published in Annals of oncology (01.09.2024)
Published in Annals of oncology (01.09.2024)
Get full text
Journal Article
MA05.11 Predictive Utility of Patient-Reported Outcomes for Survival in 1st-Line Treated Patients with a NSCLC in EMPOWER-Lung 1 and 3
Gandara, D.R., Gogishvili, M., Sezer, A., Makharadze, T., Gümüş, M., McIntyre, D.A., He, X., Yan, E., Gullo, G., Rietschel, P., Quek, R.G.
Published in Journal of thoracic oncology (01.11.2023)
Published in Journal of thoracic oncology (01.11.2023)
Get full text
Journal Article
1047P Lung-MAP S1800A: Exploratory analysis of prior immunotherapy outcomes on OS with ramucirumab plus pembrolizumab for NSCLC with PD on prior ICI
Reckamp, K., Redman, M.W., Dragnev, K., Villaruz, L., Faller, B., Al Baghdadi, T., Hines, S., Minichiello, K., Gandara, D.R., Kelly, K., Herbst, R.S.
Published in Annals of oncology (01.09.2022)
Published in Annals of oncology (01.09.2022)
Get full text
Journal Article
Long-term survival in patients with advanced non–small-cell lung cancer treated with atezolizumab versus docetaxel: Results from the randomised phase III OAK study
von Pawel, J., Bordoni, R., Satouchi, M., Fehrenbacher, L., Cobo, M., Han, J.Y., Hida, T., Moro-Sibilot, D., Conkling, P., Gandara, D.R., Rittmeyer, A., Gandhi, M., Yu, W., Matheny, C., Patel, H., Sandler, A., Ballinger, M., Kowanetz, M., Park, K.
Published in European journal of cancer (1990) (01.01.2019)
Published in European journal of cancer (1990) (01.01.2019)
Get full text
Journal Article
Fast progression in patients treated with a checkpoint inhibitor (cpi) vs chemotherapy in OAK, a phase III trial of atezolizumab (atezo) vs docetaxel (doc) in 2L+ NSCLC
Gandara, D.R., Reck, M., Morris, S., Cardona, A., Mendus, D., Ballinger, M., Rittmeyer, A.
Published in Annals of oncology (01.12.2018)
Published in Annals of oncology (01.12.2018)
Get full text
Journal Article
MA06.05 CodeBreaK 101: Safety and Efficacy of Sotorasib with Carboplatin and Pemetrexed in KRAS G12C-Mutated Advanced NSCLC
Clarke, J.M., Felip, E., Li, B.T., Ruffinelli, J.C., Garrido, P., Zugazagoitia, J., Goldberg, S.B., Ramalingam, S.S., Victoria, I., Puri, S., Gandara, D.R., Varrieur, T., Edmonds, S., Palmer, K., Snyder, W., Govindan, R., Rybkin, I.
Published in Journal of thoracic oncology (01.11.2023)
Published in Journal of thoracic oncology (01.11.2023)
Get full text
Journal Article